GlycoNex (ROCO:4168) Days Sales Outstanding : 0.00 (As of Mar. 2025)

View and export this data going back to 2012. Start your Free Trial

What is GlycoNex Days Sales Outstanding?

GlycoNex's average Accounts Receivable for the three months ended in Mar. 2025 was NT$0.00 Mil. GlycoNex's Revenue for the three months ended in Mar. 2025 was NT$13.57 Mil. Hence, GlycoNex's Days Sales Outstanding for the three months ended in Mar. 2025 was 0.00.

The historical rank and industry rank for GlycoNex's Days Sales Outstanding or its related term are showing as below:

ROCO:4168' s Days Sales Outstanding Range Over the Past 10 Years
Min: 0.62 Med: 13.44 Max: 160.11
Current: 7.17

During the past 13 years, GlycoNex's highest Days Sales Outstanding was 160.11. The lowest was 0.62. And the median was 13.44.

ROCO:4168's Days Sales Outstanding is ranked better than
96.57% of 845 companies
in the Biotechnology industry
Industry Median: 69.43 vs ROCO:4168: 7.17

GlycoNex's Days Sales Outstanding declined from Mar. 2024 (0.25) to Mar. 2025 (0.00).

GlycoNex Days Sales Outstanding Historical Data

The historical data trend for GlycoNex's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GlycoNex Days Sales Outstanding Chart

GlycoNex Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Days Sales Outstanding

Get a 7-Day Free Trial

12.95

12.20

2.40

5.10

0.62

GlycoNex Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Days Sales Outstanding	Get a 7-Day Free Trial															0.25	19.21	22.83	30.90	-

Competitive Comparison of GlycoNex's Days Sales Outstanding

For the Biotechnology subindustry, GlycoNex's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GlycoNex's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, GlycoNex's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where GlycoNex's Days Sales Outstanding falls into.

Save Embed

;

Save Embed

;

GlycoNex Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

GlycoNex's Days Sales Outstanding for the fiscal year that ended in Dec. 2024 is calculated as

	Days Sales Outstanding (A: Dec. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )	/	Revenue (A: Dec. 2024 )	*	Days in Period
=	( (0.025	+	0)	/	1 )	/	14.701	*	365
=	0.025					/	14.701	*	365
=	0.62

GlycoNex's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

	Days Sales Outstanding (Q: Mar. 2025 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2024 )	+	Accounts Receivable (A: Mar. 2025 ))	/	count )	/	Revenue (A: Mar. 2025 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	13.569	*	365 / 4
=	0					/	13.569	*	365 / 4
=	0.00

GlycoNex (ROCO:4168) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

GlycoNex Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of GlycoNex's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

GlycoNex Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GlycoNex Inc (ROCO:4168) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

Section 1, Xintai 5th Road, 8th Floor, No. 97, Xizhi District, New Taipei City, TWN, 221

Website

http://www.glyconex.com.tw

GlycoNex Inc is a Taiwan based company engaged in the development of cancer drugs from the combination of glycosphingolipid antigen and human monoclonal antibody technologies. It has a panel of antibodies that targets various carbohydrate antigens. The antibodies are cloned from hybridoma, engineered to improve stability, and can serve as reagents with applications that include ELISA, Western blot, flow cytometry, and TLC immunostaining. The Company also provides antibody research services to its academic and industrial clients. The other services provided by the firm include functional evaluation and antibody engineering. The company has two segments which are antibody new drugs and exclusive investment. It earns the majority of its revenue from the antibody new drugs segment.

GlycoNex Headlines

No Headlines